New strategies in melanoma: entering the era of combinatorial therapy

Area of Science:

• Oncology
• Immunology
• Pharmacology

Background:

• Metastatic melanoma treatment has significantly advanced with targeted therapies and immunotherapies.
• Understanding patient and tumor characteristics is crucial for optimizing treatment response.

Purpose of the Study:

• To identify patient and tumor features predictive of response to current therapies.
• To elucidate mechanisms of resistance to inform the development of next-generation treatments.

Main Methods:

• Analysis of clinical data and molecular profiles of patients with metastatic melanoma.
• Investigating biomarkers associated with therapeutic efficacy and resistance.

Main Results:

• Identification of key molecular and clinical factors influencing response to targeted therapy and immunotherapy.
• Characterization of common resistance mechanisms in metastatic melanoma.

Conclusions:

• Precise patient selection can be improved by understanding individual tumor and patient profiles.
• Targeting novel pathways and rational drug combinations are essential for overcoming resistance and improving outcomes in metastatic melanoma.